Regeneron Pharmaceuticals Inc (REGN)
894.28
-4.10
(-0.46%)
USD |
NASDAQ |
Apr 16, 16:00
895.89
+1.61
(+0.18%)
After-Hours: 17:27
Regeneron Pharmaceuticals Cash from Investing (Quarterly): -66.20M for Dec. 31, 2023
Cash from Investing (Quarterly) Chart
Historical Cash from Investing (Quarterly) Data
| Date | Value |
|---|---|
| December 31, 2023 | -66.20M |
| September 30, 2023 | -496.30M |
| June 30, 2023 | -2.387B |
| March 31, 2023 | -235.70M |
| December 31, 2022 | -1.858B |
| September 30, 2022 | 192.30M |
| June 30, 2022 | -413.90M |
| March 31, 2022 | -1.705B |
| December 31, 2021 | -2.013B |
| September 30, 2021 | -2.439B |
| June 30, 2021 | 125.80M |
| March 31, 2021 | -1.059B |
| December 31, 2020 | -305.00M |
| September 30, 2020 | -775.80M |
| June 30, 2020 | 1.453B |
| March 31, 2020 | -443.20M |
| December 31, 2019 | -208.70M |
| September 30, 2019 | -207.00M |
| June 30, 2019 | -836.00M |
| March 31, 2019 | -776.10M |
| December 31, 2018 | -265.90M |
| September 30, 2018 | -286.70M |
| June 30, 2018 | -485.00M |
| March 31, 2018 | -425.40M |
| December 31, 2017 | -335.76M |
| Date | Value |
|---|---|
| September 30, 2017 | -358.88M |
| June 30, 2017 | -170.41M |
| March 31, 2017 | -140.14M |
| December 31, 2016 | -271.25M |
| September 30, 2016 | -405.85M |
| June 30, 2016 | -326.01M |
| March 31, 2016 | -43.68M |
| December 31, 2015 | -123.30M |
| September 30, 2015 | -283.17M |
| June 30, 2015 | -371.65M |
| March 31, 2015 | -129.48M |
| December 31, 2014 | 56.64M |
| September 30, 2014 | -123.07M |
| June 30, 2014 | -118.12M |
| March 31, 2014 | -236.23M |
| December 31, 2013 | -109.95M |
| September 30, 2013 | -214.45M |
| June 30, 2013 | 116.63M |
| March 31, 2013 | -147.68M |
| December 31, 2012 | 91.10M |
| September 30, 2012 | -48.75M |
| June 30, 2012 | -139.19M |
| March 31, 2012 | 15.77M |
| December 31, 2011 | -33.91M |
| September 30, 2011 | -0.903M |
Cash From Investing Definition
Cash from Investing is a major line item of the statement of cash flows. This metric tracks the movement of cash flows for the overall investing activities of the company. A few examples of investing activities include net change in PP&E, and net divestitures.
Cash from Investing (Quarterly) Range, Past 5 Years
-2.439B
Minimum
Sep 2021
1.453B
Maximum
Jun 2020
-719.83M
Average
-443.20M
Median
Mar 2020
Cash from Investing (Quarterly) Benchmarks
| Vertex Pharmaceuticals Inc | -886.50M |
| Eli Lilly and Co | -2.924B |
| CytomX Therapeutics Inc | 12.87M |
| Pfizer Inc | -11.00B |
| Puma Biotechnology Inc | -8.17M |
Cash from Investing (Quarterly) Related Metrics
| Cash from Operations (Quarterly) | 1.090B |
| Cash from Financing (Quarterly) | -446.10M |
| Free Cash Flow | 3.668B |
| Free Cash Flow Per Share (Quarterly) | 6.827 |
| Free Cash Flow to Equity (Quarterly) | 775.90M |
| Free Cash Flow to Firm (Quarterly) | 776.20M |
| Free Cash Flow Yield | 3.61% |